These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32820482)

  • 21. Hemostasis in liver disease: implications of new concepts for perioperative management.
    Weeder PD; Porte RJ; Lisman T
    Transfus Med Rev; 2014 Jul; 28(3):107-13. PubMed ID: 24721432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How do we transfuse blood components in cirrhotic patients undergoing gastrointestinal procedures?
    Yates SG; Gavva C; Agrawal D; Sarode R
    Transfusion; 2016 Apr; 56(4):791-8. PubMed ID: 26876945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AGA Clinical Practice Update: Coagulation in Cirrhosis.
    O'Leary JG; Greenberg CS; Patton HM; Caldwell SH
    Gastroenterology; 2019 Jul; 157(1):34-43.e1. PubMed ID: 30986390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hemostasis abnormalities in liver cirrhosis: myth or reality?
    Tripodi A
    Pol Arch Med Wewn; 2008; 118(7-8):445-8. PubMed ID: 18714742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel insights into the assessment of risk of upper gastrointestinal bleeding in decompensated cirrhotic children.
    Bonnet N; Paul J; Helleputte T; Veyckemans F; Pirotte T; Prégardien C; Eeckhoudt S; Hermans C; Detaille T; Clapuyt P; Menten R; Dumitriu D; Reding R; Scheers I; Varma S; Smets F; Sokal E; Stéphenne X
    Pediatr Transplant; 2019 Jun; 23(4):e13390. PubMed ID: 30888111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patients with liver cirrhosis suffer from primary haemostatic defects? Fact or fiction?
    Violi F; Basili S; Raparelli V; Chowdary P; Gatt A; Burroughs AK
    J Hepatol; 2011 Dec; 55(6):1415-27. PubMed ID: 21718668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Management of hemostasis in gastroenterology critical care].
    Mücke MM; Miesbach W; Peiffer KH; Mücke VT; Bojunga J
    Z Gastroenterol; 2020 Nov; 58(11):1099-1106. PubMed ID: 33197951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced processing of von Willebrand factor reflects disease severity and discriminates severe portal hypertension in cirrhosis.
    Langholm LL; Manon-Jensen T; Karsdal MA; Bendtsen F; Leeming DJ; Møller S
    Eur J Gastroenterol Hepatol; 2019 Aug; 31(8):1040-1048. PubMed ID: 30768435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences.
    Lisman T; Porte RJ
    Blood; 2010 Aug; 116(6):878-85. PubMed ID: 20400681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perioperative hemostatic management in the cirrhotic patient: a position paper on behalf of the Liver Intensive Care Group of Europe (LICAGE).
    Biancofiore G; Blasi A; De Boer MT; Franchini M; Hartmann M; Lisman T; Liumbruno GM; Porte RJ; Saner F; Senzolo M; Werner MJ
    Minerva Anestesiol; 2019 Jul; 85(7):782-798. PubMed ID: 30945514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of Coagulation and Anticoagulation in Liver Transplantation Candidates.
    Northup P; Reutemann B
    Liver Transpl; 2018 Aug; 24(8):1119-1132. PubMed ID: 30142249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The coagulation system in patients with end-stage liver disease.
    Valla DC; Rautou PE
    Liver Int; 2015 Jan; 35 Suppl 1():139-44. PubMed ID: 25529099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thrombopoietin Receptor Agonists in Patients with Chronic Liver Disease.
    Khemichian S; Terrault NA
    Semin Thromb Hemost; 2020 Sep; 46(6):682-692. PubMed ID: 32820479
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mixed Fibrinolytic Phenotypes in Decompensated Cirrhosis and Acute-on-Chronic Liver Failure with Hypofibrinolysis in Those With Complications and Poor Survival.
    Blasi A; Patel VC; Adelmeijer J; Azarian S; Hernandez Tejero M; Calvo A; Fernández J; Bernal W; Lisman T
    Hepatology; 2020 Apr; 71(4):1381-1390. PubMed ID: 31465557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coagulopathy in liver diseases.
    Pluta A; Gutkowski K; Hartleb M
    Adv Med Sci; 2010; 55(1):16-21. PubMed ID: 20513645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of haemostatic alterations and associated disorders in cirrhosis in Spain: A national survey.
    Fortea JI; Puente Á; Ezcurra I; Cuadrado A; Arias-Loste MT; Cabezas J; Llerena S; Iruzubieta P; Rodríguez-Lope C; Huelin P; Casafont F; Fábrega E; Crespo J
    Dig Liver Dis; 2019 Jan; 51(1):95-103. PubMed ID: 29960901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Established and new-generation antithrombotic drugs in patients with cirrhosis - possibilities and caveats.
    Lisman T; Kamphuisen PW; Northup PG; Porte RJ
    J Hepatol; 2013 Aug; 59(2):358-66. PubMed ID: 23548197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Coagulation and cirrhosis: new insight].
    Ditisheim S; Goossens N; Spahr L; Hadengue A
    Rev Med Suisse; 2012 Sep; 8(352):1652, 1654-6. PubMed ID: 22988724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemostasis and fibrinolysis in severe liver failure and their relation to hemorrhage.
    Boks AL; Brommer EJ; Schalm SW; Van Vliet HH
    Hepatology; 1986; 6(1):79-86. PubMed ID: 3943792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Occlusive portal vein thrombosis as a new marker of decompensated cirrhosis.
    Qi X; Bai M; Yang Z; Yuan S; Zhang C; Han G; Fan D
    Med Hypotheses; 2011 Apr; 76(4):522-6. PubMed ID: 21216538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.